ArticleDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2021

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.

Alejandro Campos-Murguía et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.